Insulin Resistance: New Molecular Insights
- Insulin resistance, a condition where the body's cells don't respond properly to insulin, frequently enough precedes type 2 diabetes, a chronic illness marked by high blood sugar and...
- A recent study in Cell Communication and Signaling sheds light on the molecular underpinnings of insulin resistance in skeletal muscle, perhaps revealing new targets for type 2 diabetes...
- The study focuses on the insulin receptor and its role in the development of insulin resistance.
Uncover groundbreaking insights into the role of insulin resistance and its critical link to type 2 diabetes. A recent study reveals the molecular mechanisms behind insulin resistance, focusing on skeletal muscle—the body’s primary responder to insulin. researchers are examining how PPARβ/δ regulates InsRβ protein levels.Deleting the PPARβ/δ gene in mice reduced InsRβ levels, offering a potential target for new therapies. This research highlights novel actions of this nuclear receptor with benefits for insulin resistance and DM2 giving rise to new possibilities. News Directory 3 reports on the scientific strides. The study identifies new mechanisms in the development of insulin resistance as a precursor to type 2 diabetes. Discover what’s next in the fight against diabetes.
new Insights Into the Role of insulin Resistance in Type 2 Diabetes
Updated June 18, 2025
Insulin resistance, a condition where the body’s cells don’t respond properly to insulin, frequently enough precedes type 2 diabetes, a chronic illness marked by high blood sugar and significant health risks. Skeletal muscle, the primary site for insulin-stimulated glucose disposal, is especially vulnerable.
A recent study in Cell Communication and Signaling sheds light on the molecular underpinnings of insulin resistance in skeletal muscle, perhaps revealing new targets for type 2 diabetes (DM2) drugs. The research team was led by Manuel Vázquez-Carrera of the University of Barcelona (UB), the institute of Biomedicine of the UB (IBUB), the Sant Joan de Déu Research Institute (IRSJD), and the Networking Biomedical Research Center’s Diabetes and Associated Metabolic Diseases area (CIBERDEM). Other contributors included Ricardo Rodríguez-Calvo, Antoni Camins, and Walter Wahli.
The study focuses on the insulin receptor and its role in the development of insulin resistance. Poorly managed diabetes can damage blood vessels and vital organs. While previous research has explored alterations in the metabolic pathway activated by insulin, the insulin receptor itself has received less attention.
Vázquez-Carrera said the insulin signaling pathway begins when insulin binds to a receptor composed of the α-subunit (InsRα) and the β-subunit (InsRβ). He added that this binding activates the β-subunit, initiating a metabolic cascade that enables glucose transporters to move to the cell membrane, facilitating glucose entry.
The research assessed whether peroxisome proliferator-activated receptor (PPAR) β/δ can modulate InsRβ levels in mouse muscle. Vázquez-Carrera noted that deleting the PPARβ/δ gene in mice reduced InsRβ protein levels in skeletal muscle, while the PPARβ/δ agonist GW501516 increased these levels.
Vázquez-Carrera also said that the reduction of InsRβ levels in cultured myotubes, caused by endoplasmic reticulum stress, was partially reversed by the PPARβ/δ agonist. He added that the agonist decreased reticulum stress and lysosomal activity, which degrades the InsRβ protein, potentially explaining the compound’s beneficial effect.
The study also found that levels of ephrin receptor tyrosine kinase B4 (EphB4), which binds to InsRβ and promotes its degradation, increased in skeletal muscle from PPARβ/δ-deficient mice. Though, the PPARβ/δ agonist decreased these levels in non-genetically modified mice.
The findings identify new mechanisms by which PPARβ/δ regulates InsRβ protein levels in skeletal muscle. Vázquez-Carrera concluded that the research highlights new actions of this nuclear receptor, potentially explaining its beneficial effects on insulin resistance and DM2.
What’s next
Further research will explore how these findings can be translated into effective therapies for managing insulin resistance and preventing the onset of type 2 diabetes.